Literature DB >> 21641637

First-line treatment of advanced colorectal cancer.

Madeleine Hewish1, David Cunningham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641637     DOI: 10.1016/S0140-6736(11)60788-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer.

Authors:  Jung-Jin Park; Minyoung Lee
Journal:  Gut Liver       Date:  2013-11-11       Impact factor: 4.519

2.  Boosting of the enhanced permeability and retention effect with nanocapsules improves the therapeutic effects of cetuximab.

Authors:  Chao Yang; Yanli Tan; Hongzhao Qi; Junhu Zhou; Lixia Long; Qi Zhan; Yunfei Wang; Xubo Yuan; Chunsheng Kang
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

3.  The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.

Authors:  Wu Sun; Jialu Li; Likun Zhou; Jiayi Han; Rui Liu; Haiyang Zhang; Tao Ning; Zhiying Gao; Baorui Liu; Xi Chen; Yi Ba
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556

Review 4.  Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Colorectal Liver Metastases.

Authors:  Paul B Romesser; Neelam Tyagi; Christopher H Crane
Journal:  Cancers (Basel)       Date:  2021-04-01       Impact factor: 6.639

5.  Radiotherapeutic treatment options for oligotopic malignant liver lesions.

Authors:  Peter Wust; Marcus Beck; Robert Dabrowski; Oliver Neumann; Sebastian Zschaeck; David Kaul; Dominik P Modest; Carmen Stromberger; Bernhard Gebauer; Pirus Ghadjar
Journal:  Radiat Oncol       Date:  2021-03-16       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.